<VariationArchive VariationID="65758" VariationName="NM_145239.3(PRRT2):c.649dup (p.Arg217fs)" VariationType="Duplication" Accession="VCV000065758" Version="110" RecordType="classified" NumberOfSubmissions="68" NumberOfSubmitters="52" DateLastUpdated="2024-07-29" DateCreated="2013-08-17" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="76666" VariationID="65758">
      <GeneList>
        <Gene Symbol="MVP-DT" FullName="MVP divergent transcript" GeneID="112268170" HGNC_ID="HGNC:56029" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="29808644" stop="29820367" display_start="29808644" display_stop="29820367" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="PRRT2" FullName="proline rich transmembrane protein 2" GeneID="112476" HGNC_ID="HGNC:30500" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="29812193" stop="29815881" display_start="29812193" display_stop="29815881" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="29823408" stop="29827201" display_start="29823408" display_stop="29827201" Strand="+" />
          </Location>
          <OMIM>614386</OMIM>
          <Haploinsufficiency last_evaluated="2021-12-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PRRT2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-12-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PRRT2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_145239.3(PRRT2):c.649dup (p.Arg217fs)</Name>
      <CanonicalSPDI>NC_000016.10:29813694:CCCCCCCCC:CCCCCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="29813694" stop="29813695" display_start="29813694" display_stop="29813695" variantLength="1" positionVCF="29813694" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="29825015" stop="29825016" display_start="29825015" display_stop="29825016" variantLength="1" positionVCF="29825015" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <OtherNameList>
        <Name>649_650insC</Name>
      </OtherNameList>
      <ProteinChange>R217fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.29813703dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.29813703dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.29825024dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.29825024dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032039.1" sequenceAccession="NG_032039" sequenceVersion="1" change="g.6616dup">
            <Expression>NG_032039.1:g.6616dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256442.2" sequenceAccession="NM_001256442" sequenceVersion="2" change="c.649dup">
            <Expression>NM_001256442.2:c.649dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001243371.1" sequenceAccession="NP_001243371" sequenceVersion="1" change="p.Arg217fs">
            <Expression>NP_001243371.1:p.Arg217fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256443.2" sequenceAccession="NM_001256443" sequenceVersion="2" change="c.649dup">
            <Expression>NM_001256443.2:c.649dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001243372.1" sequenceAccession="NP_001243372" sequenceVersion="1" change="p.Arg217fs">
            <Expression>NP_001243372.1:p.Arg217fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145239.3" sequenceAccession="NM_145239" sequenceVersion="3" change="c.649dup" MANESelect="true">
            <Expression>NM_145239.3:c.649dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_660282.2" sequenceAccession="NP_660282" sequenceVersion="2" change="p.Arg217fs">
            <Expression>NP_660282.2:p.Arg217fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145239.2" sequenceAccession="NM_145239" sequenceVersion="2" change="c.649_650insC">
            <Expression>NM_145239.2:c.649_650insC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256442.1" sequenceAccession="NM_001256442" sequenceVersion="1" change="c.649dup">
            <Expression>NM_001256442.1:c.649dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145239.3" sequenceAccession="NM_145239" sequenceVersion="3" change="c.649dupC" MANESelect="true">
            <Expression>NM_145239.3:c.649dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145239.3" sequenceAccession="NM_145239" sequenceVersion="3" change="c.640_641insC" MANESelect="true">
            <Expression>NM_145239.3:c.640_641insC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA180353" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="614386.0001" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND Episodic kinesigenic dyskinesia 1" Accession="RCV000055991" Version="41">
        <ClassifiedConditionList TraitSetID="6917">
          <ClassifiedCondition DB="MedGen" ID="C4552000">Episodic kinesigenic dyskinesia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-06-15" SubmissionCount="14">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND not provided" Accession="RCV000188779" Version="56">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-01" SubmissionCount="12">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND Seizure" Accession="RCV000193894" Version="18">
        <ClassifiedConditionList TraitSetID="8220">
          <ClassifiedCondition DB="MedGen" ID="C0036572">Seizure</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-05" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND Infantile convulsions and choreoathetosis" Accession="RCV000153783" Version="36">
        <ClassifiedConditionList TraitSetID="8088">
          <ClassifiedCondition DB="MedGen" ID="C1865926">Infantile convulsions and choreoathetosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-12-30" SubmissionCount="13">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND Seizures, benign familial infantile, 2" Accession="RCV000585818" Version="45">
        <ClassifiedConditionList TraitSetID="8089">
          <ClassifiedCondition DB="MedGen" ID="C1853995">Seizures, benign familial infantile, 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-02-16" SubmissionCount="13">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND multiple conditions" Accession="RCV000768059" Version="10">
        <ClassifiedConditionList TraitSetID="10132">
          <ClassifiedCondition DB="MedGen" ID="C4552000">Episodic kinesigenic dyskinesia 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1865926">Infantile convulsions and choreoathetosis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1853995">Seizures, benign familial infantile, 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-01-18" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND Paroxysmal nonkinesigenic dyskinesia 1" Accession="RCV000991298" Version="9">
        <ClassifiedConditionList TraitSetID="481">
          <ClassifiedCondition DB="MedGen" ID="C4551506">Paroxysmal nonkinesigenic dyskinesia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-06-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND Episodic kinesigenic dyskinesia" Accession="RCV000791409" Version="14">
        <ClassifiedConditionList TraitSetID="44946">
          <ClassifiedCondition DB="MedGen" ID="C1868682">Episodic kinesigenic dyskinesia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND PRRT2 insufficiency" Accession="RCV001264813" Version="9">
        <ClassifiedConditionList TraitSetID="57300">
          <ClassifiedCondition>PRRT2 insufficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND PRRT2-Associated Paroxysmal Movement Disorders" Accession="RCV001563615" Version="12">
        <ClassifiedConditionList TraitSetID="69175">
          <ClassifiedCondition>PRRT2-Associated Paroxysmal Movement Disorders</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-03-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND Inborn genetic diseases" Accession="RCV002313738" Version="9">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND Self-limited familial infantile epilepsy" Accession="RCV002470742" Version="9">
        <ClassifiedConditionList TraitSetID="81928">
          <ClassifiedCondition DB="MedGen" ID="CN322666">Self-limited familial infantile epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND PRRT2-related disorder" Accession="RCV002280097" Version="11">
        <ClassifiedConditionList TraitSetID="79405">
          <ClassifiedCondition>PRRT2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-17" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND Neurodevelopmental delay" Accession="RCV002273952" Version="9">
        <ClassifiedConditionList TraitSetID="23610">
          <ClassifiedCondition DB="MedGen" ID="C4022738">Neurodevelopmental delay</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649dup (p.Arg217fs) AND See cases" Accession="RCV004584342" Version="1">
        <ClassifiedConditionList TraitSetID="16994">
          <ClassifiedCondition>See cases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-05" NumberOfSubmissions="68" NumberOfSubmitters="52" DateCreated="2013-08-17" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11179027</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22101681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22120146</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22131361</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22209761</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22243967</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22399141</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22623405</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22744660</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22782515</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22832103</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22845787</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22870186</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22875091</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22877996</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23077017</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23077024</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23077026</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23126439</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23180180</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23182655</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23299620</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23768507</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23771590</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24074546</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24370076</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24928127</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25457817</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25502464</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25522171</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25667652</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25915028</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26561923</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26598493</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33661484</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34782754</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301633</ID>
          <ID Source="BookShelf">NBK1460</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">29334453</ID>
          <ID Source="BookShelf">NBK475803</ID>
        </Citation>
        <DescriptionHistory Dated="2018-03-25">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-03-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10132" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Convulsions, infantile, with paroxysmal choreoathetosis, familial</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Infantile convulsions and choreoathetosis</ElementValue>
                <XRef ID="MONDO:0011178" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS</ElementValue>
                <XRef Type="MIM" ID="602066" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile convulsions and paroxysmal choreoathetosis, familial</ElementValue>
                <XRef ID="Infantile+convulsions+and+paroxysmal+choreoathetosis%2C+familial/3804" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ICCA</ElementValue>
                <XRef Type="MIM" ID="602066" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKD/IC</ElementValue>
                <XRef Type="MIM" ID="602066" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC.</Attribute>
                <XRef ID="NBK475803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8553" />
                <XRef ID="8553" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334453</ID>
                <ID Source="BookShelf">NBK475803</ID>
              </Citation>
              <XRef ID="31709" DB="Orphanet" />
              <XRef ID="C1865926" DB="MedGen" />
              <XRef ID="MONDO:0011178" DB="MONDO" />
              <XRef Type="MIM" ID="602066" DB="OMIM" />
            </Trait>
            <Trait ID="1006" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Seizures, benign familial infantile, 2</ElementValue>
                <XRef ID="MONDO:0011593" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BFIC2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">BFIS2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC.</Attribute>
                <XRef ID="NBK475803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16504" />
                <XRef ID="16504" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334453</ID>
                <ID Source="BookShelf">NBK475803</ID>
              </Citation>
              <XRef ID="306" DB="Orphanet" />
              <XRef ID="C1853995" DB="MedGen" />
              <XRef ID="MONDO:0011593" DB="MONDO" />
              <XRef Type="MIM" ID="605751" DB="OMIM" />
            </Trait>
            <Trait ID="1187" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PxMD-PRRT2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Episodic kinesigenic dyskinesia 1</ElementValue>
                <XRef ID="MONDO:0007494" DB="MONDO" />
                <XRef ID="MONDO:0100352" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia 10</ElementValue>
                <XRef ID="Dystonia+10/2407" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal kinesigenic choreoathetosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial Paroxysmal Kinesigenic Dyskinesia</ElementValue>
                <XRef ID="NBK1460" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DYT10</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKC</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">EKD1</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKD</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC.</Attribute>
                <XRef ID="NBK475803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8721" />
                <XRef ID="8721" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334453</ID>
                <ID Source="BookShelf">NBK475803</ID>
              </Citation>
              <XRef ID="98809" DB="Orphanet" />
              <XRef ID="C4552000" DB="MedGen" />
              <XRef ID="MONDO:0100352" DB="MONDO" />
              <XRef Type="MIM" ID="128200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6917" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1187" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PxMD-PRRT2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Episodic kinesigenic dyskinesia 1</ElementValue>
                <XRef ID="MONDO:0007494" DB="MONDO" />
                <XRef ID="MONDO:0100352" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia 10</ElementValue>
                <XRef ID="Dystonia+10/2407" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal kinesigenic choreoathetosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial Paroxysmal Kinesigenic Dyskinesia</ElementValue>
                <XRef ID="NBK1460" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DYT10</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKC</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">EKD1</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKD</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC.</Attribute>
                <XRef ID="NBK475803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8721" />
                <XRef ID="8721" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334453</ID>
                <ID Source="BookShelf">NBK475803</ID>
              </Citation>
              <XRef ID="98809" DB="Orphanet" />
              <XRef ID="C4552000" DB="MedGen" />
              <XRef ID="MONDO:0100352" DB="MONDO" />
              <XRef Type="MIM" ID="128200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8220" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="17066" Type="Finding">
              <Name>
                <ElementValue Type="Alternate">Seizures</ElementValue>
                <XRef ID="Seizures/6489" DB="Genetic Alliance" />
                <XRef ID="HP:0001250" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Seizure</ElementValue>
                <XRef ID="HP:0001250" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0036572" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001250" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001275" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001303" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002125" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002182" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002279" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002306" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002348" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002391" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002417" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002430" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002431" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002432" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002434" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002437" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002466" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002479" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002794" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006997" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0010520" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="57300" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="54652" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">PRRT2 insufficiency</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="8088" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Convulsions, infantile, with paroxysmal choreoathetosis, familial</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Infantile convulsions and choreoathetosis</ElementValue>
                <XRef ID="MONDO:0011178" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS</ElementValue>
                <XRef Type="MIM" ID="602066" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile convulsions and paroxysmal choreoathetosis, familial</ElementValue>
                <XRef ID="Infantile+convulsions+and+paroxysmal+choreoathetosis%2C+familial/3804" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ICCA</ElementValue>
                <XRef Type="MIM" ID="602066" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKD/IC</ElementValue>
                <XRef Type="MIM" ID="602066" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC.</Attribute>
                <XRef ID="NBK475803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8553" />
                <XRef ID="8553" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334453</ID>
                <ID Source="BookShelf">NBK475803</ID>
              </Citation>
              <XRef ID="31709" DB="Orphanet" />
              <XRef ID="C1865926" DB="MedGen" />
              <XRef ID="MONDO:0011178" DB="MONDO" />
              <XRef Type="MIM" ID="602066" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8089" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1006" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Seizures, benign familial infantile, 2</ElementValue>
                <XRef ID="MONDO:0011593" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BFIC2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">BFIS2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC.</Attribute>
                <XRef ID="NBK475803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16504" />
                <XRef ID="16504" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334453</ID>
                <ID Source="BookShelf">NBK475803</ID>
              </Citation>
              <XRef ID="306" DB="Orphanet" />
              <XRef ID="C1853995" DB="MedGen" />
              <XRef ID="MONDO:0011593" DB="MONDO" />
              <XRef Type="MIM" ID="605751" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="81928" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="52328" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Self-limited familial and non-familial infantile seizures</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Self-limited familial infantile epilepsy</ElementValue>
                <XRef ID="MONDO:0100024" DB="MONDO" />
              </Name>
              <XRef ID="CN322666" DB="MedGen" />
              <XRef ID="MONDO:0100024" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="79405" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="65761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">PRRT2-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="69175" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="57221" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">PRRT2-Associated Paroxysmal Movement Disorders</ElementValue>
                <XRef ID="1807091" DB="Illumina Laboratory Services, Illumina" />
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="23610" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="30638" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Neurodevelopmental delay</ElementValue>
                <XRef ID="HP:0012758" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C4022738" DB="MedGen" />
              <XRef Type="primary" ID="HP:0012758" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="16994" Type="PhenotypeInstruction" ContributesToAggregateClassification="true">
            <Trait ID="18728" Type="PhenotypeInstruction">
              <Name>
                <ElementValue Type="Preferred">See cases</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="44946" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36813" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Episodic kinesigenic dyskinesia</ElementValue>
                <XRef ID="MONDO:0044202" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS128200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal kinesigenic dyskinesia</ElementValue>
                <XRef ID="98809" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial paroxysmal dystonia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EKD</ElementValue>
                <XRef ID="MONDO:0044202" DB="MONDO" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8721" />
                <XRef ID="8721" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="98809" DB="Orphanet" />
              <XRef ID="C1868682" DB="MedGen" />
              <XRef ID="MONDO:0044202" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS128200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="481" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3280" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PxMD-PNKD</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Paroxysmal nonkinesigenic dyskinesia 1</ElementValue>
                <XRef ID="MONDO:0700089" DB="MONDO" />
                <XRef ID="MONDO:0007326" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia 8</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal dystonic choreoathetosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonkinesigenic choreoathetosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mount-Reback syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial paroxysmal choreoathetosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DYT8</ElementValue>
                <XRef Type="MIM" ID="118800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PDC</ElementValue>
                <XRef Type="MIM" ID="118800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FPD1</ElementValue>
                <XRef Type="MIM" ID="118800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PNKD1</ElementValue>
                <XRef Type="MIM" ID="118800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Familial paroxysmal nonkinesigenic dyskinesia (PNKD) is characterized by unilateral or bilateral involuntary movements. Attacks are typically precipitated by coffee, tea, or alcohol; they can also be triggered by excitement, stress, or fatigue, or can be spontaneous. Attacks involve dystonic posturing with choreic and ballistic movements, may be accompanied by a preceding aura, occur while the individual is awake, and are not associated with seizures. Attacks last minutes to hours and rarely occur more than once per day. Attack frequency, duration, severity, and combinations of symptoms vary within and among families. Age of onset is typically in childhood or early teens but can be as late as age 50 years.</Attribute>
                <XRef ID="NBK1221" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301400</ID>
                <ID Source="BookShelf">NBK1221</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <XRef ID="98810" DB="Orphanet" />
              <XRef ID="C4551506" DB="MedGen" />
              <XRef ID="MONDO:0700089" DB="MONDO" />
              <XRef Type="MIM" ID="118800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="460241" SubmissionDate="2015-09-15" DateLastUpdated="2015-10-05" DateCreated="2015-10-05">
        <ClinVarSubmissionID localKey="NM_145239.2(PRRT2):c.649dup|HP:0001250" />
        <ClinVarAccession Accession="SCV000248604" DateUpdated="2015-10-05" DateCreated="2015-10-05" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-06-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HP:0001250</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="530755" SubmissionDate="2016-05-19" DateLastUpdated="2016-06-09" DateCreated="2016-06-09">
        <ClinVarSubmissionID localKey="37130822" />
        <ClinVarAccession Accession="SCV000281646" DateUpdated="2016-06-09" DateCreated="2016-06-09" Type="SCV" Version="1" SubmitterName="Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics" OrgID="505698" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-10-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>Homo sapiens</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>Illumina</NamePlatform>
              <TypePlatform>Sequencing</TypePlatform>
              <ResultType>variant call</ResultType>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0.001855</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Insertion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" Strand="+" alternateAllele="C" referenceAllele="-" start="29825015" stop="29825016" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="962792" SubmissionDate="2016-11-14" DateLastUpdated="2015-07-30" DateCreated="2015-07-30">
        <ClinVarSubmissionID localKey="chr16:29825024dup|OMIM:128200" submittedAssembly="hg19" />
        <ClinVarAccession Accession="SCV000328734" DateUpdated="2015-07-30" DateCreated="2015-07-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22101681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22243967</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22782515</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23768507</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24074546</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22845787</ID>
          </Citation>
          <Comment>Our laboratory reported two molecular diagnoses in KCNQ2 (NM_172108.4, c.2332delC) and PRRT2 (NM_145239.2, c.649dup) in an individual with Ohtahara syndrome, severe developmental delay, seizure disorder, structural brain anomalies and eye anomalies, severe hypotonia, bilateral hearing loss, and dysmorphic features.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Dual_diagnosis_variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1359926" SubmissionDate="2018-03-07" DateLastUpdated="2018-03-11" DateCreated="2018-03-11">
        <ClinVarSubmissionID localKey="10" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000693768" DateUpdated="2018-03-11" DateCreated="2018-03-11" Type="SCV" Version="1" SubmitterName="NeuroMeGen, Hospital Clinico Santiago de Compostela" OrgID="505605" OrganizationCategory="clinic" OrgAbbreviation="NeuroMeGen" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649_650insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Epilepsy_associated_variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2254294" SubmissionDate="2019-07-18" DateLastUpdated="2020-01-18" DateCreated="2020-01-18">
        <ClinVarSubmissionID localKey="NM_145239.2:c.649_650insC" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001142699" DateUpdated="2020-01-18" DateCreated="2020-01-18" Type="SCV" Version="1" SubmitterName="Molecular Diagnostics Laboratory, M Health Fairview: University of Minnesota" OrgID="506641" OrganizationCategory="laboratory" OrgAbbreviation="UMMC-MDL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22101681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26598493</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="3" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <Name>p.Arg217ProfsX8</Name>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649_650insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="118800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6034146</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2293762" SubmissionDate="2019-05-24" DateLastUpdated="2020-02-29" DateCreated="2020-02-29">
        <ClinVarSubmissionID localKey="16A2558|OMIM:605751" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001164113" DateUpdated="2020-02-29" DateCreated="2020-02-29" Type="SCV" Version="1" SubmitterName="Gntique des Maladies du Dveloppement, Hospices Civils de Lyon" OrgID="506599" OrganizationCategory="laboratory" OrgAbbreviation="HCL" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Epilepsy NGS panel</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256443.1:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>PAGEM-oct-2018</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2293864" SubmissionDate="2019-05-24" DateLastUpdated="2020-02-29" DateCreated="2020-02-29">
        <ClinVarSubmissionID localKey="17A4881|OMIM:128200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001164215" DateUpdated="2020-02-29" DateCreated="2020-02-29" Type="SCV" Version="1" SubmitterName="Gntique des Maladies du Dveloppement, Hospices Civils de Lyon" OrgID="506599" OrganizationCategory="laboratory" OrgAbbreviation="HCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-03-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Epilepsy NGS panel</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>PAGEM-oct-2018</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2305612" SubmissionDate="2019-09-17" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="UCSF116|OMIM:602066" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001167610" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="Genomic Medicine Lab, University of California San Francisco" OrgID="506696" OrganizationCategory="laboratory" OrgAbbreviation="UCSF GML" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-09-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>HiSeq</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Exome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.1:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER</StudyName>
        <StudyDescription>UCSF Program in Prenatal and Pediatric Genome Sequencing (P3EGS)</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB6305134</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2350721" SubmissionDate="2019-11-26" DateLastUpdated="2020-03-29" DateCreated="2020-03-29">
        <ClinVarSubmissionID localKey="16:29825024:G" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001192520" DateUpdated="2020-03-29" DateCreated="2020-03-29" Type="SCV" Version="1" SubmitterName="HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology" OrgID="505530" OrganizationCategory="laboratory" OrgAbbreviation="HA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG codes: PVS1, PM1, PP1, PP5</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">16:29825024:G:BR00030</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Intrauterine growth retardation</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001511" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Small for gestational age</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001518" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Birth length less than 3rd percentile</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0003561" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Anemia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001903" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Cardiomyopathy</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001638" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Congenital microcephaly</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0011451" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of blood and blood-forming tissues</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001871" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Hearing impairment</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000365" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-SouthSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB6615704</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2466097" SubmissionDate="2020-04-27" DateLastUpdated="2020-05-04" DateCreated="2020-05-04">
        <ClinVarSubmissionID localKey="20A765" submittedAssembly="GRCh37" title="20A765" />
        <ClinVarAccession Accession="SCV001244945" DateUpdated="2020-05-04" DateCreated="2020-05-04" Type="SCV" Version="1" SubmitterName="Gntique des Maladies du Dveloppement, Hospices Civils de Lyon" OrgID="506599" OrganizationCategory="laboratory" OrgAbbreviation="HCL" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2">
              <Name>proline rich transmembrane protein 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.1:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>20A765</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2477389" SubmissionDate="2020-02-25" DateLastUpdated="2020-05-31" DateCreated="2020-05-31">
        <ClinVarSubmissionID localKey="CV_49|OMIM:128200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001251443" DateUpdated="2020-05-31" DateCreated="2020-05-31" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SNVs_Oct_2019</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2850337" SubmissionDate="2020-10-08" DateLastUpdated="2020-11-14" DateCreated="2020-11-14">
        <ClinVarSubmissionID localKey="NM_001256442.1:c.649dup|PRRT2 insufficiency" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001443008" DateUpdated="2020-11-14" DateCreated="2020-11-14" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Review of the variants reported in Reuter et al., 2017, PMID: 28097321: PVS1,PM2, PM3; observed in two families</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>biparental</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">severe ID</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">seizures</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">bruxism</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">self-mutilation</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.1:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <Name>
              <ElementValue Type="Preferred">PRRT2 insufficiency</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8291144</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2696596" SubmissionDate="2020-11-24" DateLastUpdated="2020-12-12" DateCreated="2020-07-04">
        <ClinVarSubmissionID localKey="NM_001256442.1:c.649dupC|OMIM:602066" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001368515" DateUpdated="2020-12-12" DateCreated="2020-07-04" Type="SCV" Version="2" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS4,PM1,PP5.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.1:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8622351</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2896556" SubmissionDate="2021-01-13" DateLastUpdated="2021-01-26" DateCreated="2021-01-26">
        <ClinVarSubmissionID localKey="NM_001256442.1:c.649dup|OMIM:605751" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001469261" DateUpdated="2021-01-26" DateCreated="2021-01-26" Type="SCV" Version="1" SubmitterName="Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City" OrgID="506517" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-07">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.1:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8885808</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3414364" SubmissionDate="2021-06-14" DateLastUpdated="2021-06-19" DateCreated="2021-06-19">
        <ClinVarSubmissionID localKey="PED8966.1|HPO:HP:0001250" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001737060" DateUpdated="2021-06-19" DateCreated="2021-06-19" Type="SCV" Version="1" SubmitterName="Equipe Genetique des Anomalies du Developpement, Universit de Bourgogne" OrgID="506039" OrganizationCategory="laboratory" OrgAbbreviation="GADteam" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0001250" />
          </Trait>
        </TraitSet>
        <Comment>Homozygous, both variants are inherited from each parent</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB9847331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3417320" SubmissionDate="2021-06-14" DateLastUpdated="2021-06-19" DateCreated="2021-06-19">
        <ClinVarSubmissionID localKey="PED6180.1|OMIM:128200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001737112" DateUpdated="2021-06-19" DateCreated="2021-06-19" Type="SCV" Version="1" SubmitterName="Equipe Genetique des Anomalies du Developpement, Universit de Bourgogne" OrgID="506039" OrganizationCategory="laboratory" OrgAbbreviation="GADteam" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9847716</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3462805" SubmissionDate="2021-07-22" DateLastUpdated="2021-07-31" DateCreated="2021-07-31">
        <ClinVarSubmissionID localKey="NM_145239.3:c.649dup" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001760953" DateUpdated="2021-07-31" DateCreated="2021-07-31" Type="SCV" Version="1" SubmitterName="New York Genome Center" OrgID="507558" OrganizationCategory="laboratory" OrgAbbreviation="NYGC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29334453</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26598493</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24370076</ID>
          </Citation>
          <Comment>The inherited c.649dup (p.Arg217ProfsTer8) variant identified in the PRRT2 gene is the duplication of a single nucleotide, resulting in the frameshift and premature termination of the protein approximately 8 amino acids downstream (coding exon 2/4). This variant is found in 21 heterozygous individuals in gnomAD(v3.0), with an allele frequency of 1.49e-4. This variant is reported in ClinVar as Pathogenic (VarID:65758), and is the most common pathogenic PRRT2 variant identified in affected individuals [PMID:29334453; PMID:26598493; PMID:24370076]. Functional studies suggest this variant is subject to rapid nonsense mediated decay [PMID:25457817]. Given this, the inherited c.649dup (p.Arg217ProfsTer8) variant identified in the PRRT2 gene is reported as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">NYGC Assertion Criteria 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/hhfhf6ms/nygc_assertion_criteria_2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">whole genome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-NYCKidSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10060875</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3506269" SubmissionDate="2021-08-09" DateLastUpdated="2021-08-14" DateCreated="2021-08-14">
        <ClinVarSubmissionID localKey="1807596" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001786591" DateUpdated="2021-08-14" DateCreated="2021-08-14" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22101681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22243967</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22399141</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22832103</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23299620</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26598493</ID>
          </Citation>
          <Comment>The PRRT2 c.649dupC (p.Arg217ProfsTer8) variant results in a frameshift and is predicted to result in premature termination or absence of the protein. Across a selection of the available literature, the p.Arg217ProfsTer8 variant has been identified in approximately 78% of all 1444 individuals with published PRRT2 variants (Chen et al. 2011; Heron et al. 2012; Ono et al. 2012; Lee et al. 2012; Becker et al. 2013; Ebrahimi-Fakhari et al. 2015). The phenotype of affected individuals includes paroxysmal kinesigenic dyskinesia, benign familial infantile epilepsy, and infantile convulsions and choreoathetosis. The p.Arg217ProfsTer8 variant was found to segregate with disease in many familial cases with high penetrance, although incomplete penetrance in several families has been described (Chen et al. 2011; Heron et al. 2012; Ono et al. 2012; Becker et al. 2013). The p.Arg217ProfsTer8 variant is reported at a frequency of 0.0001727 in the African/African-American population of the Genome Aggregation Database. PRRT2 is a transmembrane protein, and the p.Arg217ProfsTer8 variant is expected to disrupt the transmembrane domain (Chen et al. 2011). Functional studies demonstrated absence of this truncated protein in transfected cell lines and cultured hippocampal neurons (Lee et al. 2012). Co-transfection of p.Arg217ProfsTer8 with wild-type PRRT2 demonstrated normal expression of wild-type PRRT2 and low/undetectable expression of truncated PRRT2, suggesting haploinsufficiency as the disease mechanism (Lee et al. 2012). Based on the collective evidence and application of ACMG criteria, the variant is classified as pathogenic for PRRT2-associated paroxysmal movement disorders.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSLVariantClassificationCriteria RUGD 01 April 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dy7elfgy/icslvariantclassificationcriteria_rugd_01_april_2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="GC" referenceAllele="G" start="29825015" stop="29825015" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PRRT2-Associated Paroxysmal Movement Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10148256</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3785357" SubmissionDate="2021-09-23" DateLastUpdated="2021-09-26" DateCreated="2021-09-26">
        <ClinVarSubmissionID localKey=":Chr.16_29825015_29825015_G_GC|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001931576" DateUpdated="2021-09-26" DateCreated="2021-09-26" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, University Medical Center Utrecht" OrgID="274978" OrganizationCategory="laboratory" OrgAbbreviation="GDL-UMCU" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="GC" referenceAllele="G" start="29825015" stop="29825015" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10419633</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3950432" SubmissionDate="2021-11-05" DateLastUpdated="2021-11-11" DateCreated="2021-11-11">
        <ClinVarSubmissionID localKey="16-29825015-G-GC" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002012092" DateUpdated="2021-11-11" DateCreated="2021-11-11" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is observed in the gnomAD v2.1.1 (https://gnomad.broadinstitute.org/) dataset at total allele frequency of [0.003103. The variant has been reported multiple times as an established pathogenic variant (ClinVar ID: VCV000065758.42, PS4). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002373" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002282" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.1:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10606558</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3061333" SubmissionDate="2022-02-27" DateLastUpdated="2022-03-01" DateCreated="2021-04-13">
        <ClinVarSubmissionID localKey="PED7150.11|OMIM:605751" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001554493" DateUpdated="2022-03-01" DateCreated="2021-04-13" Type="SCV" Version="2" SubmitterName="Equipe Genetique des Anomalies du Developpement, Universit de Bourgogne" OrgID="506039" OrganizationCategory="laboratory" OrgAbbreviation="GADteam" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">34782754</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9330413</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5006925" SubmissionDate="2022-08-09" DateLastUpdated="2022-08-15" DateCreated="2022-08-15">
        <ClinVarSubmissionID localKey="NM_145239.3:c.649dup|HPO:HP:0012758" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002559023" DateUpdated="2022-08-15" DateCreated="2022-08-15" Type="SCV" Version="1" SubmitterName="Centre de Biologie Pathologie Gntique, Centre Hospitalier Universitaire de Lille" OrgID="505759" OrganizationCategory="laboratory" OrgAbbreviation="CHRUL" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0012758" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11909744</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5022188" SubmissionDate="2022-07-12" DateLastUpdated="2022-09-03" DateCreated="2022-09-03">
        <ClinVarSubmissionID localKey="53613782|PRRT2-related disorder" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002568212" DateUpdated="2022-09-03" DateCreated="2022-09-03" Type="SCV" Version="1" SubmitterName="Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center" OrgID="1019" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PVS1, PS4, PP1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PRRT2-related disorder</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11782039</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1455864" SubmissionDate="2017-11-06" DateLastUpdated="2022-10-01" DateCreated="2015-07-30">
        <ClinVarSubmissionID localKey="NM_145239.2:c.649dupC|OMIM:602066" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000747727" DateUpdated="2022-10-01" DateCreated="2015-07-30" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26598493</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22101681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22120146</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22131361</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22209761</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_660282.2:p.Arg217Profs*8</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614386.0001" Type="Allelic variant" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1865926" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Abbrev="GeneReviews" Type="review">
          <ID Source="PubMed">29334453</ID>
          <ID Source="BookShelf">NBK475803</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1455865" SubmissionDate="2017-11-06" DateLastUpdated="2022-10-01" DateCreated="2018-03-11">
        <ClinVarSubmissionID localKey="NM_145239.2:c.649dupC|OMIM:605751" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000747728" DateUpdated="2022-10-01" DateCreated="2018-03-11" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26598493</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22101681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22120146</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22131361</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22209761</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_660282.2:p.Arg217Profs*8</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614386.0001" Type="Allelic variant" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1853995" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Abbrev="GeneReviews" Type="review">
          <ID Source="PubMed">29334453</ID>
          <ID Source="BookShelf">NBK475803</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5038466" SubmissionDate="2022-10-01" DateLastUpdated="2022-10-08" DateCreated="2022-10-08">
        <ClinVarSubmissionID localKey="NM_145239.3:c.649dupC|OMIM:602066" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002577560" DateUpdated="2022-10-08" DateCreated="2022-10-08" Type="SCV" Version="1" SubmitterName="Laboratory of Medical Genetics, National &amp; Kapodistrian University of Athens" OrgID="506664" OrganizationCategory="laboratory" OrgAbbreviation="LMG-NKUA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PVS1, PS3, PP5</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12117196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5043090" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_145239.3:c.649dup|OMIM:128200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002581620" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="5" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="587778771" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PS3, PS4, PP1</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2268099" SubmissionDate="2022-12-20" DateLastUpdated="2022-12-24" DateCreated="2020-02-03">
        <ClinVarSubmissionID localKey="483-20200121" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001149892" DateUpdated="2022-12-24" DateCreated="2020-02-03" Type="SCV" Version="2" SubmitterName="Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU Mnchen" OrgID="500240" OrganizationCategory="clinic" OrgAbbreviation="IHG-MRI-TUM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Classification criteria August 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/inodbbrd/classification_criteria.pdf</URL>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001332" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0100660" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001336" />
              </Trait>
            </TraitSet>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001263" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001324" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0002076" />
              </Trait>
            </TraitSet>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0002069" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001655" />
              </Trait>
            </TraitSet>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0007166" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001332" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="GC" referenceAllele="G" start="29825015" stop="29825015" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MRIHUMGEN_STATUS_20220809</SubmissionName>
          <SubmissionName>SUB6902622</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5437068" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_145239.3:c.649dup|OMIM:128200;602066;605751" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002792003" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5502753" SubmissionDate="2022-12-17" DateLastUpdated="2023-01-07" DateCreated="2023-01-07">
        <ClinVarSubmissionID localKey="NM_145239.2:c.649dupC|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002818270" DateUpdated="2023-01-07" DateCreated="2023-01-07" Type="SCV" Version="1" SubmitterName="Al Jalila Childrens Genomics Center, Al Jalila Childrens Speciality Hospital" OrgID="507199" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12445851</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7182319" SubmissionDate="2023-03-23" DateLastUpdated="2023-03-26" DateCreated="2023-03-26">
        <ClinVarSubmissionID localKey="SUB12970818" submittedAssembly="hg19" title="SUB12970818" />
        <ClinVarAccession Accession="SCV003842254" DateUpdated="2023-03-26" DateCreated="2023-03-26" Type="SCV" Version="1" SubmitterName="Lifecell International Pvt. Ltd" OrgID="507720" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">22101681</ID>
          </Citation>
          <Comment>A Heterozygous Frameshift variant c.640_641insC in Exon 2 of the PRRT2 gene that results in the amino acid substitution p.Arg217fs*8 was identified. The observed variant is novel in gnomAD exomes and genomes. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score . Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Pathogenic/LikelyPathogenic (Variant ID: 65758). This variant has been identified in patients with infantile choreoathetosis and paroxysmal kinesigenic dyskinesia (Chen WJ et al., 2011). Based on the above evidence this variant has been classified as Pathogenic according to the ACMG guidelines.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Asian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2">
              <Name>proline rich transmembrane protein 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_145239.3:exon 2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="rs587778771" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.640_641insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12970818</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7522376" SubmissionDate="2023-07-25" DateLastUpdated="2023-07-29" DateCreated="2023-07-29">
        <ClinVarSubmissionID localKey="NM_145239.2:c.649dupC|MedGen:C4552000" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004020389" DateUpdated="2023-07-29" DateCreated="2023-07-29" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">33661484</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25457817</ID>
          </Citation>
          <Comment>Variant summary: PRRT2 c.649dupC (p.Arg217ProfsX8) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.0037 in 135540 control chromosomes, however this information is unreliable due to low quality metrics at this position as indicated by analysis filters incorporated in gnomAD. c.649dupC has been reported in the literature in multiple individuals affected with PRRT2-related conditions (e.g., Ji_2021). At least one publication reports experimental evidence evaluating an impact on protein function, demonstrating that approximately 80% of mutated transcripts are degraded by nonsense-mediated decay and residual mutated transcripts yield an N-terminally truncated protein (e.g., Wu_2014). The following publications have been ascertained in the context of this evaluation (PMID: 33661484, 25457817). 39 ClinVar submitters have submitted clinical-significance assessments for this variant to ClinVar after 2014, and all submitters classified the variant as pathogenic or likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4552000" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13707883</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7566240" SubmissionDate="2023-10-15" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="NM_145239.3:c.649dup|OMIM:602066" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004042676" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India" OrgID="505991" OrganizationCategory="laboratory" OrgAbbreviation="KMC-MAHE" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13902210</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7570574" SubmissionDate="2023-10-20" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="c953e573-b132-4580-ac92-cb60734560ca" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV004046802" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University Hospital of Duesseldorf" OrgID="505956" OrganizationCategory="clinic" OrgAbbreviation="UKD-HHU" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="16" alternateAllele="GC" referenceAllele="G" start="29813694" stop="29813694" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">fc60fa3b-7ce4-4555-aa93-f2f3d42711b0</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13918474</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7569999" SubmissionDate="2023-09-19" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="NM_001256442.1:c.649dup|PRRT2-Related Disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004046274" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This frameshifting variant in exon 2 of 3 introduces a premature stop codon and is therefore predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant is a recurrent cause of benign familial infantile epilepsy, infantile convulsions and choreoathetosis, and paroxysmal kinesigenic dyskinesia (PMID: 23299620, 22101681, 22870186, 22877996, 25667652). The c.649dup (p.Arg217ProfsTer8) variant is present in the gnomAD population database at a frequency of 0.3% (514/165666); however, quality metrics indicate the frequency data for this variant in the population databases is considered unreliable in the gnomAD database. Based on the available evidence, the c.649dup (p.Arg217ProfsTer8) variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.1:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PRRT2-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13808474</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1198449" SubmissionDate="2024-01-03" DateLastUpdated="2024-01-26" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="A1801|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000614795" DateUpdated="2024-01-26" DateCreated="2016-12-06" Type="SCV" Version="5" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" OrgAbbreviation="ADX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22870186</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23077017</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23077026</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22131361</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23077024</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22875091</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22209761</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24370076</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23771590</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25522171</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25502464</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22101681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22243967</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22782515</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23126439</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23182655</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22120146</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22623405</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22399141</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11179027</ID>
          </Citation>
          <Comment>This variant is expected to result in the loss of a functional protein. The frequency of this variant in the general population appears higher than would generally be expected for pathogenic variants in this gene, however, the data have failed quality metrics and thus are not useful in evaluating the pathogenicity of this variant (Genome Aggregation Database (gnomAD), Cambridge, MA (URL: http://gnomad.broadinstitute.org)). This variant has not been reported in control populations composed of more than 4,000 samples and varying ethnicities, which is consistent with the pathogenicity of this variant (PMID: 22243967, 22870186, 22875091, 23077024, 23077026, 22399141, 22209761, 22101681, 22131361, 25522171). This variant associates with various PRRT2-related disorders in multiple families, and is also reported to have reduced penetrance and variable expression between and within families (PMID: 23077026, 22782515, 23126439, 22120146, 22623405, 23077017, 23182655, 23771590, 24370076, 25502464). This variant appears to occur de novo in multiple individuals with various PRRT2-related disorders (PMID: 23077026, 22399141).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12478070</SubmissionName>
          <SubmissionName>SUB14108777</SubmissionName>
          <SubmissionName>SUB8819545</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3963478" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="55a03fecd8add9922b14dd787e8624f5fcd031c121f163b9ce452c985ec0ecd4|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002019531" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="50711" SubmissionDate="2013-08-14" DateLastUpdated="2024-03-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="614386.0001_EPISODIC KINESIGENIC DYSKINESIA 1" title="PRRT2, 1-BP DUP, 649C_EPISODIC KINESIGENIC DYSKINESIA 1" />
        <ClinVarAccession Accession="SCV000045455" DateUpdated="2024-03-10" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of 6 unrelated Han Chinese families with episodic kinesigenic dyskinesia-1 (EKD1; 128200), Chen et al. (2011) identified a heterozygous 1-bp duplication (649dupC) in exon 2 of the PRRT2 gene in the proline-rich domain, resulting in a frameshift and introduction of a stop codon 7 amino acids downstream of the insertion (Arg217ProfsTer8). The mutation was found by exome sequencing of a large 4-generation family with 17 affected individuals. The mutation completely segregated with the phenotype in each family and was not found in unaffected family members. The mutation was not found in 1,000 Han Chinese controls. Expression of a truncated form of PRRT2 in COS-7 cells showed loss of membrane targeting and localization of the truncated protein in the cytoplasm. A 189-kb common haplotype flanking the mutation was found in 3 of the families, a second different haplotype was found in 2 other families, and a third haplotype was found in the third family. Clinical features of the proband of 1 family was described in detail. He had onset at age 6 years of dystonic posturing of the head and arm, usually triggered by standing up quickly. This occurred up to 10 times per day, and lasted about 5 to 10 minutes. Brain MRI and EEG were normal at age 9 years. Treatment with carbamazepine resulted in complete symptom resolution.</Attribute>
              <Citation>
                <ID Source="PubMed">22101681</ID>
              </Citation>
              <XRef DB="OMIM" ID="128200" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Using a combination of exome sequencing and linkage analysis in a large Han Chinese family with EKD1, Wang et al. (2011) independently and simultaneously identified a heterozygous 649dupC mutation in the PRRT2 gene that completely segregated with the phenotype. The mutation was predicted to result in a truncated protein containing only 223 amino acids and lacking the transmembrane segment. Two patients in the family also had infantile convulsion and choreoathetosis syndrome (ICCA; 602066). Analysis of 3 additional Han Chinese families with EKD1 revealed that 2 carried the 649dupC mutation. The mutation was not found in 500 controls. There was some phenotypic variability: the first family had dystonia, choreoathetosis or athetosis, the second family had predominant dystonia of the upper limbs, whereas the third had predominant dystonia of the lower limbs.</Attribute>
              <Citation>
                <ID Source="PubMed">22120146</ID>
              </Citation>
              <XRef DB="OMIM" ID="602066" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In affected members of 3 unrelated families with familial infantile convulsions with paroxysmal choreoathetosis, Heron et al. (2012) identified a heterozygous 649dupC mutation. This heterozygous mutation was also found in 12 unrelated families with benign familial infantile seizures-2 (BFIS2; 605751). Overall, the 649dupC mutation was found in 15 (79%) of the 19 families with ICCA or BFIS2 studied. There was no evidence of a common haplotype among these families. The PRRT2 649dupC mutation clearly occurs at a mutation hotspot, and occurs in a homopolymer of 9 C bases adjacent to 4 G bases. This DNA sequence has the potential to form a hairpin-loop structure, possibly leading to DNA-polymerase slippage and the insertion of an extra C base during DNA replication.</Attribute>
              <Citation>
                <ID Source="PubMed">22243967</ID>
              </Citation>
              <XRef DB="OMIM" ID="605751" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Meneret et al. (2012) found that the 649dupC mutation was the most common mutation in a cohort of patients of European descent with EKD1/ICCA. The mutation was present in 17 of 22 patients with PRRT2 mutations. Several unaffected family members also carried the mutation, indicating incomplete penetrance. There were at least 5 different haplotypes with the mutation, and it was found to occur de novo in 2 patients, indicating that it is a mutation hotspot.</Attribute>
              <Citation>
                <ID Source="PubMed">22744660</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Schubert et al. (2012) identified a heterozygous 649dupC mutation in the PRRT2 gene in 39 of 49 families with BFIS2 and in 1 patient with sporadic occurrence of the disorder (77% of index cases). The patients were of German, Italian, Japanese, and Turkish origin. The 649dupC mutation, which occurs in an unstable DNA sequence of 9 cytosines, arose independently in families of different origin. Some unaffected family members also carried the mutation, indicating incomplete penetrance.</Attribute>
              <Citation>
                <ID Source="PubMed">22623405</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Ono et al. (2012) identified the 649dupC mutation in 14 of 15 Japanese families with EKD1, some of whom also had ICCA, and in 2 Japanese families with BFIS2. The mutation was shown to occur de novo in at least 1 family, suggesting that it is a mutation hotspot. EKD1, ICCA, and BFIS2 segregated with the mutation even within the same family. The findings indicated that all 3 disorders are allelic and are likely caused by a similar mechanism.</Attribute>
              <Citation>
                <ID Source="PubMed">22399141</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <Name>PRRT2, 1-BP DUP, 649C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 649C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614386.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPISODIC KINESIGENIC DYSKINESIA 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="50712" SubmissionDate="2013-08-14" DateLastUpdated="2024-03-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="614386.0001_CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS" title="PRRT2, 1-BP DUP, 649C_CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS" />
        <ClinVarAccession Accession="SCV000045456" DateUpdated="2024-03-10" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of 6 unrelated Han Chinese families with episodic kinesigenic dyskinesia-1 (EKD1; 128200), Chen et al. (2011) identified a heterozygous 1-bp duplication (649dupC) in exon 2 of the PRRT2 gene in the proline-rich domain, resulting in a frameshift and introduction of a stop codon 7 amino acids downstream of the insertion (Arg217ProfsTer8). The mutation was found by exome sequencing of a large 4-generation family with 17 affected individuals. The mutation completely segregated with the phenotype in each family and was not found in unaffected family members. The mutation was not found in 1,000 Han Chinese controls. Expression of a truncated form of PRRT2 in COS-7 cells showed loss of membrane targeting and localization of the truncated protein in the cytoplasm. A 189-kb common haplotype flanking the mutation was found in 3 of the families, a second different haplotype was found in 2 other families, and a third haplotype was found in the third family. Clinical features of the proband of 1 family was described in detail. He had onset at age 6 years of dystonic posturing of the head and arm, usually triggered by standing up quickly. This occurred up to 10 times per day, and lasted about 5 to 10 minutes. Brain MRI and EEG were normal at age 9 years. Treatment with carbamazepine resulted in complete symptom resolution.</Attribute>
              <Citation>
                <ID Source="PubMed">22101681</ID>
              </Citation>
              <XRef DB="OMIM" ID="128200" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Using a combination of exome sequencing and linkage analysis in a large Han Chinese family with EKD1, Wang et al. (2011) independently and simultaneously identified a heterozygous 649dupC mutation in the PRRT2 gene that completely segregated with the phenotype. The mutation was predicted to result in a truncated protein containing only 223 amino acids and lacking the transmembrane segment. Two patients in the family also had infantile convulsion and choreoathetosis syndrome (ICCA; 602066). Analysis of 3 additional Han Chinese families with EKD1 revealed that 2 carried the 649dupC mutation. The mutation was not found in 500 controls. There was some phenotypic variability: the first family had dystonia, choreoathetosis or athetosis, the second family had predominant dystonia of the upper limbs, whereas the third had predominant dystonia of the lower limbs.</Attribute>
              <Citation>
                <ID Source="PubMed">22120146</ID>
              </Citation>
              <XRef DB="OMIM" ID="602066" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In affected members of 3 unrelated families with familial infantile convulsions with paroxysmal choreoathetosis, Heron et al. (2012) identified a heterozygous 649dupC mutation. This heterozygous mutation was also found in 12 unrelated families with benign familial infantile seizures-2 (BFIS2; 605751). Overall, the 649dupC mutation was found in 15 (79%) of the 19 families with ICCA or BFIS2 studied. There was no evidence of a common haplotype among these families. The PRRT2 649dupC mutation clearly occurs at a mutation hotspot, and occurs in a homopolymer of 9 C bases adjacent to 4 G bases. This DNA sequence has the potential to form a hairpin-loop structure, possibly leading to DNA-polymerase slippage and the insertion of an extra C base during DNA replication.</Attribute>
              <Citation>
                <ID Source="PubMed">22243967</ID>
              </Citation>
              <XRef DB="OMIM" ID="605751" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Meneret et al. (2012) found that the 649dupC mutation was the most common mutation in a cohort of patients of European descent with EKD1/ICCA. The mutation was present in 17 of 22 patients with PRRT2 mutations. Several unaffected family members also carried the mutation, indicating incomplete penetrance. There were at least 5 different haplotypes with the mutation, and it was found to occur de novo in 2 patients, indicating that it is a mutation hotspot.</Attribute>
              <Citation>
                <ID Source="PubMed">22744660</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Schubert et al. (2012) identified a heterozygous 649dupC mutation in the PRRT2 gene in 39 of 49 families with BFIS2 and in 1 patient with sporadic occurrence of the disorder (77% of index cases). The patients were of German, Italian, Japanese, and Turkish origin. The 649dupC mutation, which occurs in an unstable DNA sequence of 9 cytosines, arose independently in families of different origin. Some unaffected family members also carried the mutation, indicating incomplete penetrance.</Attribute>
              <Citation>
                <ID Source="PubMed">22623405</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Ono et al. (2012) identified the 649dupC mutation in 14 of 15 Japanese families with EKD1, some of whom also had ICCA, and in 2 Japanese families with BFIS2. The mutation was shown to occur de novo in at least 1 family, suggesting that it is a mutation hotspot. EKD1, ICCA, and BFIS2 segregated with the mutation even within the same family. The findings indicated that all 3 disorders are allelic and are likely caused by a similar mechanism.</Attribute>
              <Citation>
                <ID Source="PubMed">22399141</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <Name>PRRT2, 1-BP DUP, 649C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 649C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614386.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="50713" SubmissionDate="2013-08-14" DateLastUpdated="2024-03-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="614386.0001_SEIZURES, BENIGN FAMILIAL INFANTILE, 2" title="PRRT2, 1-BP DUP, 649C_SEIZURES, BENIGN FAMILIAL INFANTILE, 2" />
        <ClinVarAccession Accession="SCV000045457" DateUpdated="2024-03-10" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of 6 unrelated Han Chinese families with episodic kinesigenic dyskinesia-1 (EKD1; 128200), Chen et al. (2011) identified a heterozygous 1-bp duplication (649dupC) in exon 2 of the PRRT2 gene in the proline-rich domain, resulting in a frameshift and introduction of a stop codon 7 amino acids downstream of the insertion (Arg217ProfsTer8). The mutation was found by exome sequencing of a large 4-generation family with 17 affected individuals. The mutation completely segregated with the phenotype in each family and was not found in unaffected family members. The mutation was not found in 1,000 Han Chinese controls. Expression of a truncated form of PRRT2 in COS-7 cells showed loss of membrane targeting and localization of the truncated protein in the cytoplasm. A 189-kb common haplotype flanking the mutation was found in 3 of the families, a second different haplotype was found in 2 other families, and a third haplotype was found in the third family. Clinical features of the proband of 1 family was described in detail. He had onset at age 6 years of dystonic posturing of the head and arm, usually triggered by standing up quickly. This occurred up to 10 times per day, and lasted about 5 to 10 minutes. Brain MRI and EEG were normal at age 9 years. Treatment with carbamazepine resulted in complete symptom resolution.</Attribute>
              <Citation>
                <ID Source="PubMed">22101681</ID>
              </Citation>
              <XRef DB="OMIM" ID="128200" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Using a combination of exome sequencing and linkage analysis in a large Han Chinese family with EKD1, Wang et al. (2011) independently and simultaneously identified a heterozygous 649dupC mutation in the PRRT2 gene that completely segregated with the phenotype. The mutation was predicted to result in a truncated protein containing only 223 amino acids and lacking the transmembrane segment. Two patients in the family also had infantile convulsion and choreoathetosis syndrome (ICCA; 602066). Analysis of 3 additional Han Chinese families with EKD1 revealed that 2 carried the 649dupC mutation. The mutation was not found in 500 controls. There was some phenotypic variability: the first family had dystonia, choreoathetosis or athetosis, the second family had predominant dystonia of the upper limbs, whereas the third had predominant dystonia of the lower limbs.</Attribute>
              <Citation>
                <ID Source="PubMed">22120146</ID>
              </Citation>
              <XRef DB="OMIM" ID="602066" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In affected members of 3 unrelated families with familial infantile convulsions with paroxysmal choreoathetosis, Heron et al. (2012) identified a heterozygous 649dupC mutation. This heterozygous mutation was also found in 12 unrelated families with benign familial infantile seizures-2 (BFIS2; 605751). Overall, the 649dupC mutation was found in 15 (79%) of the 19 families with ICCA or BFIS2 studied. There was no evidence of a common haplotype among these families. The PRRT2 649dupC mutation clearly occurs at a mutation hotspot, and occurs in a homopolymer of 9 C bases adjacent to 4 G bases. This DNA sequence has the potential to form a hairpin-loop structure, possibly leading to DNA-polymerase slippage and the insertion of an extra C base during DNA replication.</Attribute>
              <Citation>
                <ID Source="PubMed">22243967</ID>
              </Citation>
              <XRef DB="OMIM" ID="605751" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Meneret et al. (2012) found that the 649dupC mutation was the most common mutation in a cohort of patients of European descent with EKD1/ICCA. The mutation was present in 17 of 22 patients with PRRT2 mutations. Several unaffected family members also carried the mutation, indicating incomplete penetrance. There were at least 5 different haplotypes with the mutation, and it was found to occur de novo in 2 patients, indicating that it is a mutation hotspot.</Attribute>
              <Citation>
                <ID Source="PubMed">22744660</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Schubert et al. (2012) identified a heterozygous 649dupC mutation in the PRRT2 gene in 39 of 49 families with BFIS2 and in 1 patient with sporadic occurrence of the disorder (77% of index cases). The patients were of German, Italian, Japanese, and Turkish origin. The 649dupC mutation, which occurs in an unstable DNA sequence of 9 cytosines, arose independently in families of different origin. Some unaffected family members also carried the mutation, indicating incomplete penetrance.</Attribute>
              <Citation>
                <ID Source="PubMed">22623405</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Ono et al. (2012) identified the 649dupC mutation in 14 of 15 Japanese families with EKD1, some of whom also had ICCA, and in 2 Japanese families with BFIS2. The mutation was shown to occur de novo in at least 1 family, suggesting that it is a mutation hotspot. EKD1, ICCA, and BFIS2 segregated with the mutation even within the same family. The findings indicated that all 3 disorders are allelic and are likely caused by a similar mechanism.</Attribute>
              <Citation>
                <ID Source="PubMed">22399141</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <Name>PRRT2, 1-BP DUP, 649C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 649C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614386.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">SEIZURES, BENIGN FAMILIAL INFANTILE, 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="546723" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2015-07-30">
        <ClinVarSubmissionID localKey="251790|MedGen:C1868682" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000291481" DateUpdated="2024-02-14" DateCreated="2015-07-30" Type="SCV" Version="11" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22623405</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22744660</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22101681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22870186</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22877996</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23299620</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25667652</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg217Profs*8) in the PRRT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRRT2 are known to be pathogenic (PMID: 22623405, 22744660). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individuals with infantile seizures and/or paroxysmal kinesigenic dyskinesia (PKD) (PMID: 22101681, 22870186, 22877996, 23299620, 25667652). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 65758). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.29825015_29825016insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1868682" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8851905" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="1808677|PRRT2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004774144" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The PRRT2 c.649dupC variant is predicted to result in a frameshift and premature protein termination (p.Arg217Profs*8). This variant has previously been reported to be causative for a broad range of autosomal dominant PRRT2-related phenotypes such as paroxysmal kinesigenic dyskinesia, familial hemiplegic migraine, benign familial infantile epilepsy (BFIE), and paroxysmal torticollis (Chen et al. 2011. PubMed ID: 22101681; Li et al. 2013. PubMed ID: 23535490; Ebrahimi-Fakhari et al. 2015. PubMed ID: 26598493; Zhao et al. 2018. PubMed ID: 29285950). In addition to variable expressivity, reduced penetrance is also documented for this gene (Ebrahimi-Fakhari et al. 1993. PubMed ID: 29334453). The c.649dup is the most common pathogenic variant reported in the PRRT2 gene. Note that allele frequency estimates at this position in the gnomAD public population database may be inaccurate (https://gnomad.broadinstitute.org). In summary, we classify this variant as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.1:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PRRT2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2819777" SubmissionDate="2024-04-05" DateLastUpdated="2024-04-15" DateCreated="2020-08-15">
        <ClinVarSubmissionID localKey="4047036_NM_001256442.2:c.649dup|OMIM:605751" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001428611" DateUpdated="2024-04-15" DateCreated="2020-08-15" Type="SCV" Version="10" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Criteria applied: PVS1,PS3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000126" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0008676" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.2:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10413949</SubmissionName>
          <SubmissionName>SUB10439859</SubmissionName>
          <SubmissionName>SUB12448387</SubmissionName>
          <SubmissionName>SUB13071986</SubmissionName>
          <SubmissionName>SUB13362238</SubmissionName>
          <SubmissionName>SUB13762194</SubmissionName>
          <SubmissionName>SUB13814879</SubmissionName>
          <SubmissionName>SUB13946886</SubmissionName>
          <SubmissionName>SUB14028690</SubmissionName>
          <SubmissionName>SUB14360025</SubmissionName>
          <SubmissionName>SUB7303396</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1652507" SubmissionDate="2024-04-20" DateLastUpdated="2024-05-01" DateCreated="2018-11-08">
        <ClinVarSubmissionID localKey="a928081|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000849074" DateUpdated="2024-05-01" DateCreated="2018-11-08" Type="SCV" Version="6" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22101681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22243967</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22832103</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24928127</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25457817</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25915028</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26598493</ID>
          </Citation>
          <Comment>The c.649dupC (p.R217Pfs*8) alteration, located in exon 2 (coding exon 1) of the PRRT2 gene, results from a duplication of C at position 649, causing a translational frameshift with a predicted alternate stop codon after 8 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the c.649dupC allele has an overall frequency of 0.31% (514/165666) total alleles studied. The highest observed frequency was 0.47% (22/4682) of Ashkenazi Jewish alleles. The PRRT2 c.649dupC (p.R217Pfs*8) alteration is the most common pathogenic variant in PRRT2 and can be identified in approximately 80% of affected individuals (Ebrahimi-Fakhari, 2015). This alteration has been identified in individuals and families with paroxysmal kinesigenic dyskinesia, benign familial infantile epilepsy, hemiplegic migraine, or a combination of these presentations (Chen, 2011; Heron, 2012; Pelzer, 2014; Ebrahimi-Fakhari, 2015). Functional analysis demonstrated that the PRRT2 c.649dupC (p.R217Pfs*8) alteration results in an mRNA transcript that undergoes nonsense mediated decay (Wu, 2014). Any truncated mRNA transcript that is translated has been shown to mislocalize and is found in the cytoplasm rather than the plasma membrane (Chen, 2011). Other studies have found no detectable protein associated with the c.649dupC (p.R217Pfs*8) alteration (Li, 2015). Functional studies have also shown that the c.649dupC (p.R217Pfs*8) alteration results in a protein that is unable to interact with components of the SNARE complex or glutamate receptors (Li, 2015). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_2</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9763016" SubmissionDate="2024-05-06" DateLastUpdated="2024-05-12" DateCreated="2024-05-12">
        <ClinVarSubmissionID localKey="0240240913" submittedAssembly="GRCh37" title="0240240913" />
        <ClinVarAccession Accession="SCV005040954" DateUpdated="2024-05-12" DateCreated="2024-05-12" Type="SCV" Version="1" SubmitterName="Gntique des Maladies du Dveloppement, Hospices Civils de Lyon" OrgID="506599" OrganizationCategory="laboratory" OrgAbbreviation="HCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2">
              <Name>proline rich transmembrane protein 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Seizures</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>0240240913</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3375582" SubmissionDate="2024-05-30" DateLastUpdated="2024-06-02" DateCreated="2021-06-15">
        <ClinVarSubmissionID localKey="405878|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001715149" DateUpdated="2024-06-02" DateCreated="2021-06-15" Type="SCV" Version="3" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PVS1, PS3, PS4, PP1, PP5</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="7" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_145239.3:exon 2</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Arg217Profs*8</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13400987</SubmissionName>
          <SubmissionName>SUB14491934</SubmissionName>
          <SubmissionName>SUB9741791</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5039576" SubmissionDate="2024-06-28" DateLastUpdated="2024-07-07" DateCreated="2022-10-08">
        <ClinVarSubmissionID localKey="669561758|see cases" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002578007" DateUpdated="2024-07-07" DateCreated="2022-10-08" Type="SCV" Version="2" SubmitterName="Institute of Human Genetics, University Hospital Muenster" OrgID="507439" OrganizationCategory="clinic" OrgAbbreviation="IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG categories: PVS1,PS4,PP3,PP5,BS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Tissue>blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="GC" referenceAllele="G" start="29825015" stop="29825015" variantLength="1" />
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="587778771" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="PhenotypeInstruction">
          <Trait Type="PhenotypeInstruction">
            <Name>
              <ElementValue Type="Preferred">see cases</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12122793</SubmissionName>
          <SubmissionName>SUB14571546</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5412688" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_145239_2_PRRT2_c_649dupC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002767234" DateUpdated="2024-07-23" DateCreated="2022-12-24" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22101681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25502464</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26561923</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29334453</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with familial infantile convulsions with paroxysmal choreoathetosis (MIM#602066), episodic kinesigenic dyskinesia 1 (MIM#128200), benign familial infantile seizures 2 (MIM#605751) and self-limited familial and non-familial infantile seizures (MONDO#0100024). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0112 - The condition associated with this gene has incomplete penetrance. Reduced penetrance has been reported for paroxysmal kinesigenic dyskinesia (PMID: 29334453). (I) 0115 - Variants in this gene are known to have variable expressivity. Variation in phenotype has been reported within and between families with the same pathogenic variant (PMID: 29334453). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0310 - Variant is present in gnomAD (v2) &gt;=0.001 and &lt;0.01 for a dominant condition (514 heterozygotes, 0 homozygotes; variant did not pass quality filter). (I) 0701 - Other premature termination variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. Many NMD-predicted variants in this gene have been reported as likely pathogenic/pathogenic (ClinVar). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals (ClinVar, PMIDs: 22101681, 26561923, 25502464). (SP) 0901 - This variant has strong evidence for segregation with disease (PMIDs: 22101681, 25502464). (SP) 1205 - This variant has been shown to be maternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_2565</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0100024" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1762526" SubmissionDate="2018-12-12" DateLastUpdated="2019-04-25" DateCreated="2019-04-25">
        <ClinVarSubmissionID localKey="451|OMIM:602066;128200;605751" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000898913" DateUpdated="2019-04-25" DateCreated="2019-04-25" Type="SCV" Version="1" SubmitterName="Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago" OrgID="506344" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PRRT2 NM_145239.2 exon 2 p.Arg217Profs*8 (c.649dupC): This variant has been well reported in the literature (including an entry in GeneReviews) and has been identified in several individuals with a variety of presentations, most commonly, benign familial infantile epilepsy, infantile convulsions/choreoathetosis, and paroxysmal kinesigenic dyskinesia, segregating with disease in several affected family members (Chen 2011 PMID:22101681, Dale 2012 PMID:22845787, Heron 2012 PMID:22243967, Castiglioni 2013 PMID:23182655, He 2014 PMID:25522171, Ebrahimi-Fakhari 2015 PMID:26598493, Ebrahimi-Fakhari 2018 PMID:29334453). In addition, a review article suggests that this variant may account for 78.5% of the reported cases in the literature (Ebrahimi-Fakhari 2015 PMID:26598493). This variant is present in 8/29718 alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs772994486). Please note, disease causing variants may be present in control databases at low frequencies, reflective of the general population and/or variable expressivity. This variant is present in ClinVar, with several labs classifying this variant as pathogenic (Variation ID:65758). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant represents an addition of 1 nucleotide within a string of cytosines at position 649 and creates a premature stop codon 8 amino acids downstream from this location, which results in an absent or abnormal protein. Loss of function variants are a known mechanism of disease for this gene (Ebrahimi-Fakhari 2015 PMID:26598493). In summary, this variant is classified as pathogenic .</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="C" referenceAllele="-" start="29825015" stop="29825016" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4910108</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="361352" SubmissionDate="2015-06-09" DateLastUpdated="2019-07-31" DateCreated="2015-01-29">
        <ClinVarSubmissionID localKey="16781_000000" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000203360" DateUpdated="2019-07-31" DateCreated="2015-01-29" Type="SCV" Version="5" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000203361" DateChanged="2019-08-06" Version="4">
            <Comment Type="MergeComment">SCV000203361 was merged into SCV000203360 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2014-04-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22101681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23180180</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23182655</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation Type="general">
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="6" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Hemizygote" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="6" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="C" referenceAllele="-" start="29825024" stop="29825025" variantLength="2" />
            <GeneLocation>NM_145239.2:Ex2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI119818" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>EGL002</SubmissionName>
          <SubmissionName>PILOT_TEST_03</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2245887" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-09" DateCreated="2020-01-09">
        <ClinVarSubmissionID localKey="NC_000016.9:g.29825015_29825016insC|OMIM:128200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001140084" DateUpdated="2020-01-09" DateCreated="2020-01-09" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.29825015_29825016insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2814542" SubmissionDate="2020-08-05" DateLastUpdated="2020-08-06" DateCreated="2020-08-06">
        <ClinVarSubmissionID localKey="NM_001256442.1:c.649dup|OMIM:605751" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001426446" DateUpdated="2020-08-06" DateCreated="2020-08-06" Type="SCV" Version="1" SubmitterName="Centogene AG  - the Rare Disease Company" OrgID="279559" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.1:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7885525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3547184" SubmissionDate="2021-08-24" DateLastUpdated="2021-08-27" DateCreated="2021-08-27">
        <ClinVarSubmissionID localKey=":Chr.16_29825015_29825015_G_GC|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001807268" DateUpdated="2021-08-27" DateCreated="2021-08-27" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, Amsterdam University Medical Center" OrgID="506453" OrganizationCategory="laboratory" OrgAbbreviation="VUMC GD" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="GC" referenceAllele="G" start="29825015" stop="29825015" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10240015</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3745873" SubmissionDate="2021-09-15" DateLastUpdated="2021-09-26" DateCreated="2021-09-26">
        <ClinVarSubmissionID localKey="report_configuration_variant_id:3302993" />
        <ClinVarAccession Accession="SCV001905656" DateUpdated="2021-09-26" DateCreated="2021-09-26" Type="SCV" Version="1" SubmitterName="Institute of Medical Genetics and Applied Genomics, University Hospital Tbingen" OrgID="506385" OrganizationCategory="laboratory" OrgAbbreviation="IMGAG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SampleLocalID">DX2103770</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0011097" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="GC" referenceAllele="G" start="29825015" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3926231" SubmissionDate="2021-11-04" DateLastUpdated="2021-11-05" DateCreated="2021-11-05">
        <ClinVarSubmissionID localKey="21Ord12144|OMIM:605751" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002011753" DateUpdated="2021-11-05" DateCreated="2021-11-05" Type="SCV" Version="1" SubmitterName="Clinical Genetics Laboratory, University Hospital Schleswig-Holstein" OrgID="508136" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-21">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10612400</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3981885" SubmissionDate="2021-12-03" DateLastUpdated="2021-12-04" DateCreated="2021-12-04">
        <ClinVarSubmissionID localKey="21Ord35423|OMIM:602066" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002029206" DateUpdated="2021-12-04" DateCreated="2021-12-04" Type="SCV" Version="1" SubmitterName="Clinical Genetics Laboratory, University Hospital Schleswig-Holstein" OrgID="508136" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-25">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10756391</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3992539" SubmissionDate="2021-12-16" DateLastUpdated="2021-12-18" DateCreated="2021-12-18">
        <ClinVarSubmissionID localKey=":Chr.16_29825015_29825015_G_GC|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002036777" DateUpdated="2021-12-18" DateCreated="2021-12-18" Type="SCV" Version="1" SubmitterName="Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)" OrgID="506395" OrganizationCategory="laboratory" OrgAbbreviation="LDGA" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="GC" referenceAllele="G" start="29825015" stop="29825015" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10812803</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4033034" SubmissionDate="2021-12-21" DateLastUpdated="2022-01-15" DateCreated="2022-01-15">
        <ClinVarSubmissionID localKey="NM_001256442.1:c.649dup|OMIM:602066" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002059398" DateUpdated="2022-01-15" DateCreated="2022-01-15" Type="SCV" Version="1" SubmitterName="Centogene AG  - the Rare Disease Company" OrgID="279559" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.1:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10812468</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4040868" SubmissionDate="2022-01-18" DateLastUpdated="2022-01-22" DateCreated="2022-01-22">
        <ClinVarSubmissionID localKey="NVEM2150|MedGen:C4552000" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002061239" DateUpdated="2022-01-22" DateCreated="2022-01-22" Type="SCV" Version="1" SubmitterName="DASA" OrgID="508087" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22101681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22870186</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22877996</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25667652</ID>
          </Citation>
          <Comment>The c.649dup;p.(Arg217Profs*8) is a null frameshift variant (NMD) in the PRRT2 gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevantexon to the transcript -PVS1. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 65758; PMID: 22101681; 22870186; 22877996; 25667652) - PS4 and is allele frequency is greater than expected for disorder - BS1. In summary, the currently available evidence indicates that the variant is pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_145239.3:exon 2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="587778771" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4552000" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10963955</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="145781" SubmissionDate="2017-11-06" DateLastUpdated="2022-10-01" DateCreated="2013-10-01">
        <ClinVarSubmissionID localKey="NM_145239.2:c.649dupC|OMIM:128200" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000087045" DateUpdated="2022-10-01" DateCreated="2013-10-01" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26598493</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22101681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22120146</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22131361</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22209761</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_660282.2:p.Arg217Profs*8</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614386.0001" Type="Allelic variant" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4552000" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Abbrev="GeneReviews" Type="review">
          <ID Source="PubMed">29334453</ID>
          <ID Source="BookShelf">NBK475803</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5048722" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="22Ord18773|OMIM:128200" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002583481" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="Clinical Genetics Laboratory, University Hospital Schleswig-Holstein" OrgID="508136" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-02">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12129371</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="447148" SubmissionDate="2022-05-16" DateLastUpdated="2023-03-04" DateCreated="2015-08-07">
        <ClinVarSubmissionID localKey="GDXSV:227483" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000242403" DateUpdated="2023-03-04" DateCreated="2015-08-07" Type="SCV" Version="12" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Published functional studies indicate this variant results in decreased expression and altered cellular localization of the protein (Wu et al., 2014); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Recurrent pathogenic variant that accounts for approximately 77-93% of all pathogenic alleles in the PRRT2 gene; This variant is associated with the following publications: (PMID: 25522171, 23180180, 25502464, 23535490, 22877996, 22782515, 24661410, 22744660, 24370076, 27959697, 30182498, 30034362, 29250726, 31785815, 31901402, 31302675, 29655203, 26876767, 22101681, 25595153, 22243967, 23768507, 24074546, 22845787, 23771590, 23182655, 23126439, 24609974, 23532549, 22870186, 22623405, 27920401, 25915028, 27123484, 27172900, 28553402, 28097321, 28566192, 28525812, 29215089, 29778030, 29852413, 28018471, 29285950, 29302074, 30501978, 29132464, 30392205, 30125676, 30847922, 30814447, 31780880, 31737037, 31154286, 31722684, 32002278, 31216405, 32246320, 33126500, 34489640, 34298454, 32651081, 33391346, 33327426, 32613771, 33043084, 33258288, 32964447, 25667652, 25457817, 32860008, 33726816, 32237035)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:50517</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_104_20220504054205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_106_20220511054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7183448" SubmissionDate="2023-03-22" DateLastUpdated="2023-03-26" DateCreated="2023-03-26">
        <ClinVarSubmissionID localKey="SUB12968938" submittedAssembly="GRCh38" title="SUB12968938" />
        <ClinVarAccession Accession="SCV003842214" DateUpdated="2023-03-26" DateCreated="2023-03-26" Type="SCV" Version="1" SubmitterName="Pediatrics, Sichuan Provincial Hospital For Women And Children" OrgID="509001" OrganizationCategory="patient registry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The proband, a male, 9 months old, There was no obvious cause before the onset of convulsion, the form of Generalized tonic-clonic seizures (GTCS), which occurred about 1-2 minutes after spontaneous stop.His mother and grandfather had the same seizure up to the age of six years old, after which they healed</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory">Department of Medical Genetics and Prenatal Diagnosis, Sichuan Provincial Hospital for Women and Children</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Hemizygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
            </TraitSet>
            <Comment>ACGM classified this mutation as likely pathogenic (PVS1+PP1+PP3)</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="16" start="29813703" stop="29813703" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">c.649dup</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12968938</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7113184" SubmissionDate="2023-05-02" DateLastUpdated="2023-05-06" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="NM_145239.3:c.649dup|OMIM:602066" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003807085" DateUpdated="2023-05-06" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein" OrgID="508506" OrganizationCategory="laboratory" OrgAbbreviation="LABO-HIAE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG classification criteria: PVS1 very strong, PS3 supporting, PM6 moderated, PP1 strong, BS1 strong</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <Description>Paired-end whole-genome sequencing</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12925816</SubmissionName>
          <SubmissionName>SUB13231220</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7681209" SubmissionDate="2023-11-03" DateLastUpdated="2023-11-11" DateCreated="2023-11-11">
        <ClinVarSubmissionID localKey="20100119964" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004101501" DateUpdated="2023-11-11" DateCreated="2023-11-11" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The frameshift c.649dup (p.Arg217ProfsTer8) variant has been reported previously in heterozygous state in patients affected with Convulsions, familial infantile, with paroxysmal choreoathetosis (Swoboda KJ. et. al., 2000; Lee HY et. al., 2012).This position has been reported to be a mutational hotspot (Mao CY et. al., 2014) and as such, this variant is considered one of the most common, recurrent causes of both PKD and benign familial infantile seizures (Steinlein OK et. al., 2012; Becker F et. al., 2013). The p.Arg217ProfsTer8 variant is novel (not in any individuals) in 1000 Genomes and has an allele frequency of 0.4% in gnomAD database. This variant has been reported to the ClinVar database as Pathogenic. This mutation creates a premature translational stop signal (p.Arg217Profs*8) and is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRRT2 are known to be pathogenic. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002069" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002353" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003128" />
              </Trait>
              <Comment>Age: 6 months Consanguinity: present Clinical details: - C/o multiple convulsions since 1 month Age of onset: 5 months Birth history: FTND; CIAB; Accepting feeds well Investigations: - MRI brain: Reported Normal (? cerebral atrophy) - EEG: Abnormal - Increased Lactate Clinical suspicion: genetic epilepsy</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.2:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13951554</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9762783" SubmissionDate="2024-05-02" DateLastUpdated="2024-05-12" DateCreated="2024-05-12">
        <ClinVarSubmissionID localKey="30306300288" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005042834" DateUpdated="2024-05-12" DateCreated="2024-05-12" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The frameshift variant c.649dupp.Arg217ProfsTer8 in PRRT2 gene has been reported previously in heterozygous state in individuals affected with benign familial infantile epilepsy, infantile convulsions/choreoathetosis, and paroxysmal kinesigenic dyskinesia Wang Y, et al., 2017, Zheng W, et al., 2016. Experimental studies indicate that this variant results in decreased expression and altered cellular localization of the protein Wu L, et al., 2014. The variant is reported with 0.3% allele frequency in gnomAD Exomes and is novel not in any individuals in 1000 Genomes. This variant has been reported to the ClinVar database as Likely Pathogenic/Pathogenic multiple submissions. This variant causes a frameshift starting with codon Arginine 217, changes this amino acid to Proline residue, and creates a premature Stop codon at position 8 of the new reading frame, denoted p.Arg217ProfsTer8. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2023-03-01" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000707" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14421073</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5506967" SubmissionDate="2024-06-20" DateLastUpdated="2024-07-15" DateCreated="2023-01-21">
        <ClinVarSubmissionID localKey="30407400052" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002820154" DateUpdated="2024-07-15" DateCreated="2023-01-21" Type="SCV" Version="4" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The observed frameshift c.649dup(p.Arg217ProfsTer8) variant in PRRT2 gene has been reported previously in heterozygous state in individual(s) affected with infantile seizures and/or paroxysmal kinesigenic dyskinesia (PKD) (Steinlein et al., 2012; Chen GH., 2015). This variant is reported with the allele frequency of 0.4% in the gnomAD Exomes. This variant has been reported to the ClinVar database as Pathogenic by multiple submitters. This variant causes a frameshift starting with codon Arginine 217, changes this amino acid to Proline residue, and creates a premature Stop codon at position 8 of the new reading frame, denoted p.Arg217ProfsTer8. This variant is predicted to cause loss of normal protein function through protein truncation. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRRT2 are known to be pathogenic (Mneret et al., 2012). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2023-03-20" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000707" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12521961</SubmissionName>
          <SubmissionName>SUB14457248</SubmissionName>
          <SubmissionName>SUB14457274</SubmissionName>
          <SubmissionName>SUB14550130</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2470046" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="100459|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001248447" DateUpdated="2024-07-15" DateCreated="2020-05-12" Type="SCV" Version="22" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PRRT2: PVS1, PP1:Strong, PS2, PS4:Moderate</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="87" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="GC" referenceAllele="G" start="29825015" stop="29825015" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2268099" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001263" MappingRef="HP">
        <MedGen CUI="C0557874" Name="Global developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5022188" TraitType="Disease" MappingType="Name" MappingValue="PRRT2-related disorder" MappingRef="Preferred">
        <MedGen CUI="None" Name="PRRT2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2819777" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000126" MappingRef="HP">
        <MedGen CUI="C0020295" Name="Hydronephrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2268099" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001332" MappingRef="HP">
        <MedGen CUI="C0013421" Name="Dystonic disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2350721" TraitType="Finding" MappingType="Name" MappingValue="Cardiomyopathy" MappingRef="Preferred">
        <MedGen CUI="C0878544" Name="Cardiomyopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7522376" TraitType="Disease" MappingType="XRef" MappingValue="C4552000" MappingRef="MedGen">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="50713" TraitType="Disease" MappingType="Name" MappingValue="SEIZURES, BENIGN FAMILIAL INFANTILE, 2" MappingRef="Alternate">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2268099" TraitType="Disease" MappingType="XRef" MappingValue="HP:0002076" MappingRef="HP">
        <MedGen CUI="C0149931" Name="Migraine" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="447148" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="530755" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5437068" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5039576" TraitType="PhenotypeInstruction" MappingType="Name" MappingValue="see cases" MappingRef="Preferred">
        <MedGen CUI="None" Name="See cases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2268099" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5506967" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2850337" TraitType="Finding" MappingType="Name" MappingValue="seizures" MappingRef="Preferred">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3785357" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5437068" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2293762" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2350721" TraitType="Finding" MappingType="Name" MappingValue="Small for gestational age" MappingRef="Preferred">
        <MedGen CUI="C0235991" Name="Small for gestational age" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1762526" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2350721" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2850337" TraitType="Finding" MappingType="Name" MappingValue="PRRT2 insufficiency" MappingRef="Preferred">
        <MedGen CUI="None" Name="PRRT2 insufficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3547184" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3417320" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950432" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002282" MappingRef="HP">
        <MedGen CUI="C0266491" Name="Gray matter heterotopia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3963478" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1455864" TraitType="Disease" MappingType="XRef" MappingValue="C1865926" MappingRef="MedGen">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5048722" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3981885" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2819777" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1198449" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7566240" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950432" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2268099" TraitType="Disease" MappingType="XRef" MappingValue="HP:0002069" MappingRef="HP">
        <MedGen CUI="C0494475" Name="Bilateral tonic-clonic seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5043090" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2350721" TraitType="Finding" MappingType="Name" MappingValue="Hearing impairment" MappingRef="Preferred">
        <MedGen CUI="C1384666" Name="Hearing impairment" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3375582" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7681209" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002353" MappingRef="HP">
        <MedGen CUI="C0151611" Name="EEG abnormality" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2814542" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2254294" TraitType="Disease" MappingType="XRef" MappingValue="118800" MappingRef="OMIM">
        <MedGen CUI="C4551506" Name="Paroxysmal nonkinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2350721" TraitType="Finding" MappingType="Name" MappingValue="Birth length less than 3rd percentile" MappingRef="Preferred">
        <MedGen CUI="C1855650" Name="Birth length less than 3rd percentile" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="50711" TraitType="Disease" MappingType="Name" MappingValue="EPISODIC KINESIGENIC DYSKINESIA 1" MappingRef="Preferred">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3745873" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011097" MappingRef="HP">
        <MedGen CUI="C1527366" Name="Epileptic spasm" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9763016" TraitType="Disease" MappingType="Name" MappingValue="Seizures" MappingRef="Preferred">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2268099" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001332" MappingRef="HP">
        <MedGen CUI="C0013421" Name="Dystonic disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2466097" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5506967" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000707" MappingRef="HP">
        <MedGen CUI="C0497552" Name="Abnormality of the nervous system" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2293864" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1762526" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1652507" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2850337" TraitType="Finding" MappingType="Name" MappingValue="bruxism" MappingRef="Preferred">
        <MedGen CUI="C0006325" Name="Bruxism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3462805" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7183448" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950432" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002373" MappingRef="HP">
        <MedGen CUI="C0009952" Name="Febrile seizure (within the age range of 3 months to 6 years)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="145781" TraitType="Disease" MappingType="XRef" MappingValue="C4552000" MappingRef="MedGen">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3061333" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="361352" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2819777" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008676" MappingRef="HP">
        <MedGen CUI="C0266324" Name="Congenital megaureter" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2850337" TraitType="Finding" MappingType="Name" MappingValue="self-mutilation" MappingRef="Preferred">
        <MedGen CUI="C0036601" Name="Self-mutilation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2896556" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1359926" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3414364" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2268099" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001336" MappingRef="HP">
        <MedGen CUI="C0027066" Name="Myoclonus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5412688" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0100024" MappingRef="MONDO">
        <MedGen CUI="CN322666" Name="Self-limited familial infantile epilepsy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2350721" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of blood and blood-forming tissues" MappingRef="Preferred">
        <MedGen CUI="C0850715" Name="Abnormality of blood and blood-forming tissues" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5502753" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7681209" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003128" MappingRef="HP">
        <MedGen CUI="C0001125" Name="Lactic acidosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2268099" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001655" MappingRef="HP">
        <MedGen CUI="C0016522" Name="Patent foramen ovale" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2350721" TraitType="Finding" MappingType="Name" MappingValue="Anemia" MappingRef="Preferred">
        <MedGen CUI="C0002871" Name="Anemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2268099" TraitType="Disease" MappingType="XRef" MappingValue="HP:0100660" MappingRef="HP">
        <MedGen CUI="C0013384" Name="Dyskinesia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3462805" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3745873" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7570574" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3992539" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7113184" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2268099" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001324" MappingRef="HP">
        <MedGen CUI="C0151786" Name="Muscle weakness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="962792" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9762783" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2305612" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1455865" TraitType="Disease" MappingType="XRef" MappingValue="C1853995" MappingRef="MedGen">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="546723" TraitType="Disease" MappingType="XRef" MappingValue="C1868682" MappingRef="MedGen">
        <MedGen CUI="C1868682" Name="Episodic kinesigenic dyskinesia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2477389" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2350721" TraitType="Finding" MappingType="Name" MappingValue="Congenital microcephaly" MappingRef="Preferred">
        <MedGen CUI="C2677180" Name="Primary microcephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2850337" TraitType="Finding" MappingType="Name" MappingValue="severe ID" MappingRef="Preferred">
        <MedGen CUI="CN219809" Name="severe ID" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2819777" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3506269" TraitType="Disease" MappingType="Name" MappingValue="PRRT2-Associated Paroxysmal Movement Disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="PRRT2-Associated Paroxysmal Movement Disorders" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1762526" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2470046" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7183448" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5437068" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3745873" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="50712" TraitType="Disease" MappingType="Name" MappingValue="CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS" MappingRef="Alternate">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2350721" TraitType="Finding" MappingType="Name" MappingValue="Intrauterine growth retardation" MappingRef="Preferred">
        <MedGen CUI="C0015934" Name="Fetal growth restriction" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4040868" TraitType="Disease" MappingType="XRef" MappingValue="C4552000" MappingRef="MedGen">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2696596" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950432" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7681209" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5039576" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7182319" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7681209" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002069" MappingRef="HP">
        <MedGen CUI="C0494475" Name="Bilateral tonic-clonic seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5038466" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3926231" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2268099" TraitType="Disease" MappingType="XRef" MappingValue="HP:0007166" MappingRef="HP">
        <MedGen CUI="C0752210" Name="Paroxysmal dyskinesia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8851905" TraitType="Disease" MappingType="Name" MappingValue="PRRT2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="PRRT2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569999" TraitType="Disease" MappingType="Name" MappingValue="PRRT2-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="PRRT2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2245887" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9762783" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000707" MappingRef="HP">
        <MedGen CUI="C0497552" Name="Abnormality of the nervous system" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5006925" TraitType="Finding" MappingType="XRef" MappingValue="HP:0012758" MappingRef="HP">
        <MedGen CUI="C4022738" Name="Neurodevelopmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4033034" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2268099" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001526180</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

